About Peptyde Bio
Peptyde Bio discovers, designs, and characterizes novel anti-microbial peptides (AMPs). These peptides can complement or replace chemical fungicides because they are effective, environmentally friendly, and have lower cost of development compared to traditional fungicides. With a strong pipeline developed through robust design capabilities, Peptyde Bio enables its partners to more quickly and cost effectively commercialize AMP-based biofungicides. Peptyde Bio was launched by the Danforth Technology Company in June 2022.
- Founding: 2022
- Focus : Service
- Industry : Biotechnology